Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function

[1]  Rohit Loomba,et al.  Link between gut‐microbiome derived metabolite and shared gene‐effects with hepatic steatosis and fibrosis in NAFLD , 2018, Hepatology.

[2]  A. Gasbarrini,et al.  Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease , 2018, Hepatology.

[3]  P. Gentileschi,et al.  Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women , 2018, Nature Medicine.

[4]  Luke R. Thompson,et al.  Best practices for analysing microbiomes , 2018, Nature Reviews Microbiology.

[5]  Rob Knight,et al.  Current understanding of the human microbiome , 2018, Nature Medicine.

[6]  P. Almgren,et al.  Connection Between BMI-Related Plasma Metabolite Profile and Gut Microbiota , 2018, The Journal of clinical endocrinology and metabolism.

[7]  C. Moylan,et al.  JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study , 2018 .

[8]  C. Manichanh,et al.  Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis , 2018, Hepatology.

[9]  Peer Bork,et al.  Extensive impact of non-antibiotic drugs on human gut bacteria , 2018, Nature.

[10]  Wei Jia,et al.  Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis , 2018, Nature Reviews Gastroenterology & Hepatology.

[11]  E. Comelli,et al.  Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance , 2018, Scientific Reports.

[12]  David A. Drew,et al.  Metatranscriptome of human fecal microbial communities in a cohort of adult men , 2018, Nature Microbiology.

[13]  R. Gibbs,et al.  The gut mycobiome of the Human Microbiome Project healthy cohort , 2017, Microbiome.

[14]  J. Casadesús,et al.  Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts , 2017, Front. Med..

[15]  Evgeni Levin,et al.  Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. , 2017, Cell metabolism.

[16]  A. Gasbarrini,et al.  Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[17]  Jian-Gao Fan,et al.  Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. , 2017, Hepatobiliary & pancreatic diseases international : HBPD INT.

[18]  Ruixin Zhu,et al.  Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD , 2017, Gut.

[19]  R. Schwabe,et al.  The gut microbiome and liver cancer: mechanisms and clinical translation , 2017, Nature Reviews Gastroenterology &Hepatology.

[20]  T. Manohar,et al.  Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis , 2017, Euroasian journal of hepato-gastroenterology.

[21]  D. Pieper,et al.  Uncovering the trimethylamine-producing bacteria of the human gut microbiota , 2017, Microbiome.

[22]  Shibu Yooseph,et al.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. , 2017, Cell metabolism.

[23]  V. Leone,et al.  Microbial metabolites in health and disease: Navigating the unknown in search of function , 2017, The Journal of Biological Chemistry.

[24]  S. V. D. van de Graaf,et al.  Bile Acid Uptake Transporters as Targets for Therapy , 2017, Digestive Diseases.

[25]  F. Bäckhed,et al.  Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling , 2017, Digestive Diseases.

[26]  P. Paci,et al.  Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach , 2017, Hepatology.

[27]  W. Stremmel,et al.  Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine , 2017, PloS one.

[28]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[29]  W. D. de Vos,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.

[30]  F. Anania,et al.  Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. , 2016, Gastroenterology.

[31]  L. Drago,et al.  Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? , 2016, Archives of medical science : AMS.

[32]  Lanjuan Li,et al.  Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease , 2016, Scientific Reports.

[33]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[34]  J Stypułkowski,et al.  Profile of Gut Microbiota Associated With the Presence of Hepatocellular Cancer in Patients With Liver Cirrhosis. , 2016, Transplantation proceedings.

[35]  E. Comelli,et al.  Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease , 2016, PloS one.

[36]  Lawrence A. David,et al.  The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota , 2016, Hepatology.

[37]  A. Horvath,et al.  Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. , 2016, American journal of physiology. Gastrointestinal and liver physiology.

[38]  A. Margolles,et al.  Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..

[39]  W. Bockelmann,et al.  Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions , 2016, Front. Microbiol..

[40]  P. Hylemon,et al.  Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.

[41]  Angela C. Poole,et al.  Proton pump inhibitors alter the composition of the gut microbiota , 2015, Gut.

[42]  R. Gomis,et al.  Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice , 2015, Scientific Reports.

[43]  Jens Roat Kultima,et al.  Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota , 2016 .

[44]  E. Esteve,et al.  Obesity changes the human gut mycobiome , 2015, Scientific Reports.

[45]  Ellen E. Blaak,et al.  Short-chain fatty acids in control of body weight and insulin sensitivity , 2015, Nature Reviews Endocrinology.

[46]  K. Brouwer,et al.  Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis , 2015, Digestive Diseases and Sciences.

[47]  W. D. de Vos,et al.  Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. , 2015, Clinical nutrition.

[48]  J. Schattenberg,et al.  Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease , 2015, Gut.

[49]  D. Philpott,et al.  Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. , 2015, Cell metabolism.

[50]  F. Rey,et al.  Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.

[51]  B. Neuschwander‐Tetri,et al.  Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial , 2015, The Lancet.

[52]  Jing Li,et al.  Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease , 2015, Scientific Reports.

[53]  N. Reo,et al.  Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease. , 2015, FEMS microbiology ecology.

[54]  I. Albert,et al.  Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease. , 2015, The Journal of clinical investigation.

[55]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[56]  Jens Roat Kultima,et al.  An integrated catalog of reference genes in the human gut microbiome , 2014, Nature Biotechnology.

[57]  D. Brenner,et al.  Interactions between the intestinal microbiome and liver diseases. , 2014, Gastroenterology.

[58]  Timothy J. Laurent,et al.  A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter , 2014, PloS one.

[59]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[60]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[61]  O. Paciello,et al.  Effects of Sodium Butyrate and Its Synthetic Amide Derivative on Liver Inflammation and Glucose Tolerance in an Animal Model of Steatosis Induced by High Fat Diet , 2013, PloS one.

[62]  Masoumeh Sikaroodi,et al.  Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[63]  Jun Yu,et al.  Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study , 2013, PloS one.

[64]  S. Hazen,et al.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.

[65]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[66]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[67]  D. Jain,et al.  Molecular analysis of gut microbiota in obesity among Indian individuals , 2012, Journal of Biosciences.

[68]  P. Holt,et al.  A high-fat diet is associated with endotoxemia that originates from the gut. , 2012, Gastroenterology.

[69]  S. Zeisel,et al.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression , 2012, Current opinion in gastroenterology.

[70]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[71]  D. Raoult,et al.  Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii , 2011, International Journal of Obesity.

[72]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[73]  A. Fodor,et al.  Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.

[74]  N. Nowak,et al.  Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis , 2010, PloS one.

[75]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[76]  G. La Torre,et al.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.

[77]  C. McClain,et al.  Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. , 2008, Journal of hepatology.

[78]  M. McCarthy,et al.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.

[79]  E. V. Mccollum,et al.  THE PREVENTION BY CHOLINE OF LIVER CIRRHOSIS IN RATS ON HIGH FAT, LOW PROTEIN DIETS. , 1941, Science.